Preclinical CRO in
cancer research
Your partner for in vitro and in vivo services in oncology
ANTINEO SERVICES 2026
Our Strengths
OUR VERSATILITY
Reactivity, adaptability and flexibility
OUR PERSONNALIZED ADVICE
Advisory board of preclinical and clinical experts to understand your needs and projects
SECONDARY RESISTANCE MODELS
Established and characterized through RNAseq and immunophenotyping of the tumor microenvironment
OUR COMPETITIVE PRICES
To provide our customers with excellent value for money
Who we are
History
A spin-off from an academic team at the Cancer Research Center of Lyon (CRCL)
Expertise
10 years-old company
specialized in proof-of
concept studies in oncology
Track record
300+ studies
60+ sponsors
6 collaborative projects
(syngeneic, PDX, xenografts)
90 human & equal syngeneic
ADC efficacy study in the HER2+ model NCI-N87 (gastric cancer)
Antitumoral efficacy studies
Toxicity, MTD, PK studies
Original resistant models
Immunophenotyping
Up to 5 lasers and 29-markers panels Off the shelf or customized panels
Bioluminescence imaging
Antitumoral cell toxicity
Determination of IC50 / EC50
Continuous-monitoring studies
Immune cells activation
ADCC and ADCP assays
T cell activation by iFNy measurements
ADCC assays with fresh NK cells
Flow cytometry analysis
Up to 5 lasers and 29-markers panels
Off the shelf or customized panels
Splenocytes activation
Ensures precise extrusion bioprinting of standardized tumors models, enhancing reproducibility
CELL VIABILITY
Assessing live cell populations
in tumor models
PROLIFERATION
Monitoring growth rates of various cell types
DRUG SENSITIVITY
Analyzing responses to
targeted therapeutic agents
MULTICELLULAR MODELS
Creating complex environments
for accurate testing
They trust us : Pulsalys | Roche | Université de Tours | CRCL
Client Testimonial
« We have really benefited from Antineo expertise in preclinical services which has allowed us to establish proof of concept in xenograft models that they have identified, in-licensed and developed for us. Project management is very professionally done with regular reporting in a proactive mode. It is really nice to work with the whole team ! »
— Cécile Bougeret, Vice President of Operations, Evextabio
